Enteral nutrition is a way of providing nutrition support via the gastrointestinal tract for patient unable to otherwise meet nutrient requirement by oral. Over the years, many new enteral nutrition formulas have been created to serve a variety of indented use. The Enteral nutrition formula products are considered as medical good by U.S Food and Drug Administration and therefore are not regulated as pharmaceutical to some extent. The study covers the market for the enteral feeding formula consumed via tube feeding for people who are unable to meet their nutritional needs through an oral diet e.g. due to a lack of appetite or swallowing difficulties
Growth in the enteral nutrition market is driven by several factors such as population demographics e.g. certain elderly people and infants with special nutritional needs, increasing incidences of diagnosed diseases and awareness of nutrition benefits in disease management. There is rising preference for enteral nutrition products over parenteral nutrition, due to lower cost and risk of infection during administration of intravenously delivered nutrition which further boosts the market. The expansion of the market is also explained by the shift towards home care credit to innovations in the delivery of products, which makes it possible to administer enteral nutrition therapies at home without specific medical skills. However, the enteral feeding formula market also face number of challenges such as product pricing, regulation of quality and testing etc.
The report analyses the global enteral feeding formulas market based on product, age, application, end user and geography.
The various enteral feeding formulas commercially available in the market are standard formulas, peptide formulas and specialized formulas. The standard enteral nutrition formulas are designed to meet basic micro and macronutrient requirement of individual who cannot meet nutrition meet orally, specialty EN formulas have been developed to perform pharmacological properties, such as immuno enhancing formula containing glutamic, nucleotides, arginine and omega 3 fatty acids. Growing demand for low cost nutrient formulations coupled with availability of vast varieties of standard formula drives their growth.
These formulas are used across populace of various age group including adults and paediatrics. Adults segment is likely to have maximum demand for the enteral feeding formulas market. Mostly, enteral nutrition is prescribed to patients suffering from malnutrition, cancer or gastrointestinal disorders. Increasing prevalence of chronic diseases and illness such as neurological diseases and disorders in adults are which are driving the market in adults.
The global enteral feeding formulas market finds application in oncology, gastroenterology, critical care, neurology, diabetes etc. The oncology segment held the largest market share of the enteral feeding formula, primarily due to high prevalence of malnutrition among cancer patients. Cancer patients are prone to severe malnutrition induced by the tumour or its associated therapy including tumour removal surgeries, radiations and chemotherapy which in turn surge the demand for tube feeding for nutritional support. Manufacturers develop formulas to specifically target the cancer associated conditions, thereby increasing the adoption of enteral feeding formulas among cancer patients.
The major end users of the market are hospitals, ambulatory surgical centres and home care. Hospitals accounted for the major market share in terms of revenue. Flooding demand from critically ill patients and high occurence of chronic diseases including diabetes, cancer, inflammatory bowel disease, and others are some of the key factors driving the adoption among hospitals.
Based on geography, the global enteral feeding formulas market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America accounted for the largest market share owing to the increaing growing geriatric population along with rising incidences of chronic diseases and disorders, increasing healthcare expenditure, and increasing demand for homecare. However, Asia Pacific enteral feeding formulas market is anticipated to grow at fastest CAGR.
The key competitors of this market include Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.), Nutricia (Netherlands), Aveanna Healthcare (U.S). Abbott is present in all critical regions and active on the two major primary market segments including infant clinical nutrition and enteral clinical nutrition.
The report analyses the global enteral feeding formulas market based on product, age, application, end user and geography. The various enteral feeding formulas studied in this report are standard formulas, peptide formulas and specialized formulas. These formulas are used across populace of various age group including adults and pediatrics. The market finds application in neurology, critical care, diabetes, gastro enterology and other applications. The major end users of these products are hospitals, home care, ambulatory surgical centers (ASCs) etc. The market is studied for various countries of key regions such as North America, Europe, Asia Pacific and rest of the World.
The key competitors of this market include Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.), Nutricia (Netherlands), and Aveanna Healthcare (U.S). among others.
Why to buy this report: